Califf Discusses FSMA Implementation, Opioids At Senate Hearing On Budget

The newly minted FDA commissioner faced continued criticism of the agency’s past opioid approval decisions at a hearing on its FY 2017 budget request. The hearing, which came a day after an FDA Science Board meeting on the topic of prescription painkillers, also touched on the agency’s implementation of a sweeping overhaul of its oversight of food safety and the labeling of genetically modified food, among other items. Robert Califf, in his first appearance before Congress as FDA chief, told...